Drug Overdose Deaths Among Persons Aged 10-19 Years -- United States, July 2019-December 2021
This document provides a detailed analysis of trends and characteristics of drug overdose deaths among adolescents.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This document provides a detailed analysis of trends and characteristics of drug overdose deaths among adolescents.
This is invited testimony to the U.S. Senate Finance Committee during the hearing on "Behavioral Health Care When Americans Need It: Ensuring Parity and Care Integration" about making behavioral health services accessible to Americans, including care for substance use disorders.
A clinical pharmacist from Rush University Medical Center presents an example of implementation of team-based care using telehealth for substance use disorder (SUD) care.
These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.